Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Share-based Compensation (2024 - 2026)

Updated

Impact Biomedical's Share-based Compensation was $1.44 million in Q1 2026, compared with $29,000 a year earlier.

Analysis

Impact Biomedical (IBO) Share-based Compensation (2024 - 2026) Analysis & Trends

For FY2025, Share-based Compensation at Impact Biomedical came in at $190,000, up 900.0% from FY2024.

  • In earlier years, Share-based Compensation was $19,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 357.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 160.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 234.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 362.00 Mn
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.44 Mn
Sep 30, 2025 2,000.00
Jun 30, 2025 2,000.00
Mar 31, 2025 29,000.00
Dec 31, 2024 19,000.00
API Access

Impact Biomedical Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IBO&period=max&api_key=YOUR_API_KEY